Concurrent Prescription of Trazodone and Lorazepam

Prescribing Framework

• The National Comprehensive Cancer Network supports the combination of trazodone and lorazepam for palliative care, with lorazepam used as-needed for breakthrough anxiety or agitation while trazodone is maintained on a regular daily schedule 1
• The American Academy of Sleep Medicine emphasizes that inconsistent use of trazodone leads to inadequate therapeutic effect and potential misuse 2

Clinical Indications for Combination Therapy

• The National Comprehensive Cancer Network explicitly recommends adding lorazepam 0.5-2 mg every 4-6 hours for severe delirium with refractory agitation despite high doses of neuroleptics 1
• Lorazepam 1 mg at bedtime and morning of treatment, with trazodone for baseline mood stabilization, is recommended for anticipatory nausea/anxiety in chemotherapy patients 4

Safety Considerations and Monitoring

• Both medications cause central nervous system depression, with the primary concern being excessive sedation rather than a specific drug-drug interaction 3
• Regular lorazepam use leads to tolerance, addiction, depression, and cognitive impairment in approximately 10% of patients 3

Special Populations

• The American Geriatrics Society recommends starting trazodone at 25-50 mg and lorazepam at 0.25-0.5 mg in elderly patients, with heightened risk of falls, cognitive impairment, and respiratory depression requiring closer monitoring 3